ZTS

Zoetis Inc

155.45

0.66+0.42%

Opening15:59 08/27 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE155.40/154.79

TODAY RANGE154.51-156.11

VOL1.25M

MARKET CAP68.89B

52 WEEK RANGE138.77-197.92

AVG VOL (3M)3.17M

% TURNOVER0.28%

TURNOVER--

P/E (TTM)26.75

% RANGE1.03%

EPS(TTM)5.81

P/E(FORWARD)25.99

P/B13.87

BVPS11.21

DIVIDEND2.000

P/S7.53

BETA--

DIV YIELD1.29%

FREE FLOAT MKT CAP68.83B

SHARES OUTSTANDING443.18M

NEXT EARNINGS11/03-11/07

FREE FLOAT442.76M

LOT SIZE1

EX-DATE07/18/2025

News

Press Releases

Financial Reports

Profile

Seeking Alpha·2d ago
Zoetis: Why I Decided To Invest In The Stock
TipRanks·6d ago
Analysts Offer Insights on Healthcare Companies: Option Care Health (OPCH) and Zoetis (ZTS)
Seeking Alpha·08/20 08:16
Pharmaceuticals Industry Analysis: Eli Lilly Tops My Tier Two
Seeking Alpha·08/19 11:05
Artisan Global Opportunities Fund Q2 2025 Commentary
TipRanks·08/18 15:58
Zoetis Enters Underwriting Agreement for Senior Notes
NASDAQ·08/12 14:50
See Which Of The Latest 13F Filers Holds ZTS
Seeking Alpha·08/12 05:26
Zoetis prices $1.85B senior notes
Dow Jones·08/11 12:33
Zoetis Is Maintained at Overweight by Piper Sandler
TipRanks·08/11 10:38
Piper Sandler Keeps Their Buy Rating on Zoetis (ZTS)
TipRanks·08/11 10:30
Zoetis price target raised to $215 from $210 at Piper Sandler
Seeking Alpha·08/08 09:45
Ave Maria Growth Fund Q2 2025 Commentary
Seeking Alpha·08/08 09:30
Ave Maria Rising Dividend Fund Q2 2025 Commentary
Seeking Alpha·08/07 21:33
Elanco Animal Health Q2: Rising Innovation Revenue, Initiate At Buy
TipRanks·08/07 12:58
Leerink Partners Keeps Their Hold Rating on Zoetis (ZTS)
Seeking Alpha·08/07 12:10
Elanco spikes after Q2 beat, guidance raise

Same Industry

Name/Symbol

Change%

Price

Zoetis Inc

ZTS

+0.42%

155.45

McKesson

MCK

+0.45%

683.57

Biogen Inc

BIIB

-0.28%

136.34

Amgen Inc

AMGN

-0.57%

287.92

Bristol-Myers Squibb Company Celegne Contingent Value Rights

CELG-RT

-3.32%

0.0349

Shire

SHPG

0.00%

179.20

Celgene

CELG

0.00%

108.24

Lilly Eli & Co

LLY

-0.20%

734.55

Therapeuticsmd Inc

TXMD

+1.69%

1.14

Johnson & Johnson

JNJ

+0.12%

176.70

Abbvie Inc

ABBV

-0.08%

208.19

Gilead Sciences Inc

GILD

-0.72%

113.92

Novo-Nordisk A/S

NVO

+2.05%

56.48

Bristol-Myers Squibb Co

BMY

+0.82%

47.60

Alexion Pharms

ALXN

0.00%

182.50

Pfizer

PFE

+0.58%

25.07

Sanofi FR

SNY

-0.34%

50.13

Sanofi FR

GCVRZ

0.00%

0.8711

Novartis

NVS

+0.24%

126.95

Dr Reddys Labs

RDY

+0.14%

14.23

GSK PLC

GSK

+0.26%

39.94

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.